Chest

Article	Citations
Antithrombotic Therapy for VTE Disease	479
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019	355
Executive Summary	256
Hospital-Acquired Infections in Critically Ill Patients With COVID-19	245
Persistent Exertional Intolerance After COVID-19	218
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19	175
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma	171
Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension	164
Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza	147
Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019	146
Robotic Bronchoscopy for Peripheral Pulmonary Lesions	142
Eosinophilic and Noneosinophilic Asthma	140
Perioperative Management of Antithrombotic Therapy	137
Screening for Lung Cancer	137
Disparities in Sleep Health and Potential Intervention Models	134
Diagnosis and Evaluation of Hypersensitivity Pneumonitis	129
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure	128
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes	128
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU	127
Medical Education During the COVID-19 Pandemic	125
The Coronavirus Disease 2019 Pandemic’s Effect on Critical Care Resources and Health-Care Providers	116
Treatment of Community-Acquired Pneumonia in Immunocompromised Adults	115
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis	109
Pulmonary Thrombosis and Thromboembolism in COVID-19	102
Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions	96

Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism	96
Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality	95
Chest CT Imaging Signature of Coronavirus Disease 2019 Infection	90
Treatment of Mycobacterium abscessus Pulmonary Disease	88
Chest CT in COVID-19 at the ED: Validation of the COVID-19 Reporting and Data System (CO-RADS) and CT Severity Score	80
Right Ventricular Dysfunction in Early Sepsis and Septic Shock	80
VTE in ICU Patients With COVID-19	75
Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019	73
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units	73
Feasibility of a 5G-Based Robot-Assisted Remote Ultrasound System for Cardiopulmonary Assessment of Patients With Coronavirus Disease 2019	73
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer	71
Relationship Between CPAP Termination and All-Cause Mortality	70
Projecting Long-term Health and Economic Burden of COPD in the United States	69
Acetazolamide for OSA and Central Sleep Apnea	69
Risk Factors for Invasive Candida Infection in Critically Ill Patients	67
Pulmonary Hypertension in Patients With COPD	66
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases	66
Symptoms of Mental Health Disorders in Critical Care Physicians Facing the Second COVID-19 Wave	66
Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception	65
Racial Bias in Pulse Oximetry Measurement Among Patients About to Undergo Extracorporeal Membrane Oxygenation in 2019-2020	64
Lung Cancer Screening Rates During the COVID-19 Pandemic	64
Age and Sex Disparities in Adherence to CPAP	64
Thromboprophylaxis in Patients With COVID-19	62
The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19	61
Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation	60
Tobacco Smoking and Risk for Pulmonary Fibrosis	60
Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic	60
Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic	59
Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm	59
Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors	58
Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	57
The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19	57
Frailty in Patients With Lung Cancer	56
The Impact of Asthma on Mortality in Patients With COVID-19	56
Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren’s	55
Air Pollution and Asthma	55
Lung Transplantation for Patients With COVID-19	54
Neonatal Lung Ultrasound and Surfactant Administration	54
Male Sex, Severe Obesity, Older Age, and Chronic Kidney Disease Are Associated With COVID-19 Severity and Mortality in New York City	53
Association Between Nocturnal Hypoxemia and Cancer Incidence in Patients Investigated for OSA	53
Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019	53
Impact of Obesity in Critical Illness	53
Systematic Review of Ozone Effects on Human Lung Function, 2013 Through 2020	52
Global Impact of Respiratory Disease	52
Variation in Early Management Practices in Moderate-to-Severe ARDS in the United States	51
Reboxetine Plus Oxybutynin for OSA Treatment	50
Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment	50
Epidemiology of Adult Pleural Disease in the United States	50
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia	50
The Predictive Value of Lung Ultrasound Scores in Developing Bronchopulmonary Dysplasia	50

A Validation Study of Four Different Cluster Analyses of OSA and the Incidence of Cardiovascular Mortality in a Hispanic Population	50
Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype	50
Endobronchial Valves for the Treatment of Advanced Emphysema	50
Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates	49
Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP	48
Incidence and Location of Atelectasis Developed During Bronchoscopy Under General Anesthesia	48
Actions Taken by US Hospitals to Prepare for Increased Demand for Intensive Care During the First Wave of COVID-19	48
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY	47
Changes in Pediatric ICU Utilization and Clinical Trends During the Coronavirus Pandemic	47
Gaps in COPD Guidelines of Low- and Middle-Income Countries	47
Sleep Apnea and Insomnia	47
Race Correction and Spirometry	46
Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease	46
Angiotensin II Infusion for Shock	46
Guided Bronchoscopy for the Evaluation of Pulmonary Lesions	46
Higher vs Lower Oxygenation Strategies in Acutely Ill Adults	45
Performance and Interpretation of Invasive Hemodynamic Exercise Testing	45
The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy	45
Risk Factors for Dysphagia in ICU Patients After Invasive Mechanical Ventilation	44
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia	44
Global Physiology and Pathophysiology of Cough	44
The Spectrum of Sleep Disorders in Parkinson Disease	44
Assessing the Physiologic Endotypes Responsible for REM- and NREM-Based OSA	43
Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers	43
Racial Differences in Adherence to Lung Cancer Screening Follow-up	43
Association of Triglyceride-Glucose Index and Lung Health	43
Progesterone in Addition to Standard of Care vs Standard of Care Alone in the Treatment of Men Hospitalized With Moderate to Severe COVID-19	42
Clinical and Genetic Spectrum of Children With Primary Ciliary Dyskinesia in China	42
Rapid Design and Implementation of Post-COVID-19 Clinics	42
Providing Outpatient Telehealth Services in the United States	42
Protein Biomarkers for COPD Outcomes	42
Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a Centralized Approach	42
High-Flow Nasal Cannula in the Immediate Postoperative Period	42
Severe Pulmonary Hypertension in COPD	42
The Influence of the COVID-19 Pandemic on ICU Organization, Care Processes, and Frontline Clinician Experiences	41
Post-ICU COVID-19 Outcomes	41
Novel Machine Learning Can Predict Acute Asthma Exacerbation	41
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism	41
The PERT Concept	41
C-reactive Protein and Risk of OSA in Four US Cohorts	41
Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation	41
Management for the Drowning Patient	41
Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019	40
Effects of Compliance With the Early Management Bundle (SEP-1) on Mortality Changes Among Medicare Beneficiaries With Sepsis	40
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry	40
A Randomized Trial of Initiation of Chronic Noninvasive Mechanical Ventilation at Home vs In-Hospital in Patients With Neuromuscular Disease and Thoracic Cage Disorder	40
Family Presence for Critically Ill Patients During a Pandemic	39
Diagnostic Outcomes and Safety of Cryobiopsy Added to Conventional Sampling Methods	39
Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis	39
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction	37
Impact of Right Ventricular Dysfunction on Short-term and Long-term Mortality in Sepsis	37
International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline	37
Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population	37
Clinical Presentation and Outcomes of Acute Pericarditis in a Large Urban Hospital in the United States of America	37
Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension	37
Inferior Vena Cava Filters	37
The Effect of a Quality Improvement Intervention on Sleep and Delirium in Critically Ill Patients in a Surgical ICU	36
Minimal Inhibitory Concentration of Clofazimine Among Clinical Isolates of Nontuberculous Mycobacteria and Its Impact on Treatment Outcome	36
The Usefulness of the Rapid Shallow Breathing Index in Predicting Successful Extubation	36
Use of Handheld Point-of-Care Ultrasound in Emergency Airway Management	36
Incidence, Risk Factors, and Effects on Outcome of Ventilator-Associated Pneumonia in Patients With Traumatic Brain Injury	35
Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019	35
Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose	35
Shared Decision-Making for Lung Cancer Screening	35
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease	35
Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicle Infusion for the Treatment of Respiratory Failure From COVID-19	34
Ventilatory Mechanics in Early vs Late Intubation in a Cohort of Coronavirus Disease 2019 Patients With ARDS	34
Development and Prospective Validation of a Deep Learning Algorithm for Predicting Need for Mechanical Ventilation	34
The Relationship Between Asthma and Cardiovascular Disease	34
Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging	34
CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury	34
Phenotypes and Subphenotypes of Patients With COVID-19	34
Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis	34
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases	33
Pulmonary Exacerbations in Adults With Cystic Fibrosis	33
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19	33
VTE Prophylaxis in Critically Ill Adults	33
The Role of Palliative Care in COPD	33
Trends and Geographic Variation in Acute Respiratory Failure and ARDS Mortality in the United States	33
Multiorgan Dysfunction After Severe Traumatic Brain Injury	33

Normative Peak Cardiopulmonary Exercise Test Responses in Canadian Adults Aged ≥40 Years	33
The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer	32
Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017	32
Proposed Quality Metrics for Lung Cancer Screening Programs	32
It Takes a Village…	32
Effect of Early Balanced Crystalloids Before ICU Admission on Sepsis Outcomes	32
Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS	32
Mass Critical Care Surge Response During COVID-19	32
Routine Frailty Screening in Critical Illness	32
Executive Summary	32
The Clinical Use of Lung MRI in Cystic Fibrosis	32
Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019	32
The Burden of Mental Illness Among Survivors of Critical Care—Risk Factors and Impact on Quality of Life	31
Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions	31
Lung Response to a Higher Positive End-Expiratory Pressure in Mechanically Ventilated Patients With COVID-19	31
Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma	30
Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management	30
A Behavior Change Intervention Aimed at Increasing Physical Activity Improves Clinical Control in Adults With Asthma	30
Achieving Safe Liberation During Weaning From VV-ECMO in Patients With Severe ARDS	30
Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS	30
Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease	30
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease	29
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome	29
Detection and Early Referral of Patients With Interstitial Lung Abnormalities	29
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia	29
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease	29
Diagnosing EVALI in the Time of COVID-19	29
Multisystem Inflammatory Syndrome in Adults	29
Antibiotic Timing and Progression to Septic Shock Among Patients in the ED With Suspected Infection	29
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19	29
Mixed Ventilatory Defects in Pulmonary Sarcoidosis	29
Lung Ultrasound for Patients With Coronavirus Disease 2019 Pulmonary Disease	29
The US Strategic National Stockpile Ventilators in Coronavirus Disease 2019	29
Seven Pillars of Small Airways Disease in Asthma and COPD	28
Fertility and Pregnancy in Cystic Fibrosis	28
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension	28
Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease	28
Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose	28
Pulmonary Manifestations of GATA2 Deficiency	28
National Trends and Disparities in Health Care Access and Coverage Among Adults With Asthma and COPD	28
Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis	28
Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia	28
Asthma-COPD Overlap	27
Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019	27
Sex and Survival After Surgery for Lung Cancer	27
Using Geospatial Analysis to Evaluate Access to Lung Cancer Screening in the United States	27
Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend	27
Framework for Integrating Equity Into Machine Learning Models	27
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19	27
Expression Quantitative Trait Methylation Analysis Reveals Methylomic Associations With Gene Expression in Childhood Asthma	27
Point-of-Care Ultrasound for Bedside Diagnosis of Lower Extremity DVT	27
Paradoxical Effect of Chest Wall Compression on Respiratory System Compliance	27
Familial Pulmonary Fibrosis	27
Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis	27
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease	27
Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD	26
Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis	26
Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD	26
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension	26
The Role of Genetic Testing in Pulmonary Fibrosis	26
Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab	26
Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis	26
Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis	26
Management of Indwelling Tunneled Pleural Catheters	26
Safety and Feasibility of a Protocolized Daily Assessment of Readiness for Liberation From Venovenous Extracorporeal Membrane Oxygenation	26
Dyspnea, Acute Respiratory Failure, Psychological Trauma, and Post-ICU Mental Health	26
Shape-Sensing Robotic-Assisted Bronchoscopy vs Digital Tomosynthesis-Corrected Electromagnetic Navigation Bronchoscopy	26
Risk Factors of Fat Embolism Syndrome After Trauma	26
Diagnosis and Management of Myositis-Associated Lung Disease	26
SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens	26
Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease	26
Interhospital Transfer of Patients With Acute Pulmonary Embolism	26
How Health-Care Organizations Implement Shared Decision-making When It Is Required for Reimbursement	25
Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension	25
Sarcoidosis	25
Phenotypes of Bronchopulmonary Dysplasia in Adults	25
United States Pulmonary Hypertension Scientific Registry	25
Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases	25
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis	25
The Changing Epidemiology of Cystic Fibrosis	25
Better With Ultrasound	25
Impact of Bronchiectasis on Incident Nontuberculous Mycobacterial Pulmonary Disease	25
Estimates of Sepsis Prevalence and Outcomes in Adult Patients in the ICU in India	25
Natural Language Processing to Identify Pulmonary Nodules and Extract Nodule Characteristics From Radiology Reports	25
Pulmonary Critical Care Fellows’ Use of and Self-reported Barriers to Learning Bedside Ultrasound During Training	25
Management of Life-Threatening Asthma	25
How We Prevent and Treat Delirium in the ICU	25
Making Effective Educational Videos for Clinical Teaching	25
Long-Term Benefits of Pulmonary Rehabilitation in Patients With COPD	24
Operational Challenges of a Low-Dose CT Lung Cancer Screening Program During the Coronavirus Disease 2019 Pandemic	24
Impact of a Multimodal Telemonitoring Intervention on CPAP Adherence in Symptomatic OSA and Low Cardiovascular Risk	24
Power Outage	24
Addressing Sex Disparities in Lung Cancer Screening Eligibility	24
An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism	24
Long-Term Disabilities of Survivors of Out-of-Hospital Cardiac Arrest	24